Sort   by:  
 Page size 
UnknownOvarian failure related to eukaryotic initiation factor 2B mutations.
Not available
S-EPMC1180314 | biostudies-literature
UnknownEvaluation of treatment response in adults with relapsing MOG-Ab-associated disease.
Not available
S-EPMC6607517 | biostudies-literature
UnknownGenotype-phenotype correlation and course of transthyretin familial amyloid polyneuropathies in France.
Not available
S-EPMC4738459 | biostudies-literature
UnknownImmune Profiling Reveals the T-Cell Effect of Ocrelizumab in Early Relapsing-Remitting Multiple Sclerosis.
Not available
S-EPMC9944617 | biostudies-literature
UnknownMD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study.
Not available
S-EPMC6061426 | biostudies-literature
UnknownDistinctive clinical presentation and pathogenic specificities of anti-AK5 encephalitis.
Not available
S-EPMC8557339 | biostudies-literature
UnknownKappa Free Light Chain Biomarkers Are Efficient for the Diagnosis of Multiple Sclerosis: A Large Multicenter Cohort Study.
Not available
S-EPMC9663206 | biostudies-literature
UnknownAssociation Between Anti-CD20 Therapies and COVID-19 Severity Among Patients With Relapsing-Remitting and Progressive Multiple Sclerosis.
Not available
S-EPMC10290250 | biostudies-literature
UnknownRelapses in Patients Treated with High-Dose Biotin for Progressive Multiple Sclerosis.
Not available
S-EPMC8116391 | biostudies-literature
UnknownComparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis.
Not available
S-EPMC6715507 | biostudies-literature
Sort   by:  
 Page size